Tirzepatide Dual GIP/GLP-1 receptor pathway research compound
Tran will discuss symptoms often linked to vitamin B12 deficiency, such as fatigue, weakness, numbness or tingling in the hands and feet, memory difficulties, or mood changes
This efficacy/security gap suggests that orforglipron is unlikely to significantly erode the market share of subcutaneous formulations
Many patients on GLP-1 medications lose an average of 10% to 15% of their body weight over 12-18 months, depending on their body mass index, dose, and adherence to a treatment plan
doi: 10.1016/j.freeradbiomed.2022.02.023 104 GaoMDengJLiuFFanAWangYWuHet al
Some patients report mild queasiness that barely interferes with daily activities, while others experience more pronounced nausea requiring dietary adjustments